Rigel Pharmaceuticals Stock (NASDAQ: RIGL)

Rigel Pharmaceuticals

RIGEL PHARMACEUTICALS INC

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Rockwell Automation, Inc.

News

Intraday Update

Markets

Movers

Trading Ideas

ANGI

ELAN

EOSE

LOPE

NRDS

OPEN

OSCR

PRCH

REZI

RIGL

VOYA

Rockwell Automation Posts Better-Than-Expected Earnings, Joins Oscar Health, Charles River Laboratories, Walt Disney, Voya Financial And Other Big Stocks Moving Higher On Wednesday

Wall Street Cautiously Optimistic About 2025, S&P 500 Projected To Rise 9-10%: CNBC Strategist Survey

Equities

Large Cap

Market Summary

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Politics

Global

Tech

ETFs

General

$BTC

ARBE

AVAV

CHPT

CRWD

SPDR Dow Jones Industrial Average ETF Trust

GRND

MRVL

RGTI

ROST

STEM

iShares Trust Barclays 20+ Year Treasury Bond Fund

TREE

VSCO

Select Sector SPDR-Consumer Discretionary

The three major indices were mostly flat in midday trading Wednesday with the S&amp;P 500 and Nasdaq slightly under the flatline and the Dow Jones up 39 points. 

Wall Street Awaits Trump&#39;s Tariff Decision, Digests Mixed Economic Data: What&#39;s Driving Markets Wednesday?

WallStreet.NYSE

ASTS

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

DAVE

GTLB

OKTA

RILY

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.

Stocks Drop As Trade War Escalates: What&#39;s Driving Markets Tuesday?

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals Inc

Press Releases

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Earnings

Rigel Provides Business Update and 2025 Outlook

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update

Abeona Therapeutics

Absci

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

aTyr Pharma

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Benitec Biopharma

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Checkpoint Therapeutics, Inc. - Common Stock

Checkpoint Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

Erasca

Heron Therapeutics

Immutep Limited - American Depositary Shares

Immutep

ITeos Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Oruka Therapeutics

Rezolute

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Verve Therapeutics

XOMA Royalty

Cantor Fitzgerald

Citigroup

B. Riley Securities

HC Wainwright & Co.

Piper Sandler

Comments

Rigel Pharmaceuticals

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell